tiprankstipranks
Trending News
More News >
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
US Market
Advertisement

Citius Pharmaceuticals (CTXR) Ownership - Who Owns Citius Pharmaceuticals?

Compare
1,723 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,255,343Insider91.77%16,716,209
1,992,243Insider17.83%3,247,356
484,649Institution4.34%789,978
243,899Institution2.18%397,555
243,899Institution2.18%397,555
66,399Institution0.59%108,230
66,383Institution0.59%108,204
60,353Insider0.54%98,375
15,075Institution0.13%24,572
12,800Institution0.11%20,864

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
484,649Institution4.34%789,978
243,899Institution2.18%397,555
66,399Institution0.59%108,230
66,383Institution0.59%108,204
15,075Institution0.13%24,572
7,693Institution0.07%12,540
4,251Institution0.04%6,929
185Institution<0.01%302

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
165,584Institution1.48%112,597
78,315Institution0.70%53,254

FAQ

Who Owns Citius Pharmaceuticals (CTXR)?
Currently, no data Available
What percentage of Citius Pharmaceuticals (CTXR) stock is held by institutional investors?
Currently, no data Available
What percentage of Citius Pharmaceuticals (CTXR) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Citius Pharmaceuticals (CTXR)?
Leonard Mazur owns the most shares of Citius Pharmaceuticals (CTXR).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis